Skip to main content

Latest SEC Filings — Page 144

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Carvana Locks In $1.66B Term Loan B to Retire 2030 Secured Notes
Form 8-KCVNA · Form 8-K · 2026-08-14
Air T Q1 FY2027: Revenue Jumps 63% to $115.5M, but Operating Loss Hits $12.8M on Rex and Arena Integration Costs
ProForm 8-KAIRT · Form 8-K · 2026-08-14
CEO Brian Shore Sells Additional $566K in Same-Day-Sale Exercise
Form 4PKE · Form 4 · 2026-08-14
Liminatus Pharma 10-Q: Going Concern Doubt, Material Weaknesses, Nasdaq Deadline Sept 3
ProForm 10-QLIMN · Form 10-Q · 2026-08-14
Largo Q2 Revenue Up 68% to $44M, Positive Adjusted EBITDA, and New Copper-PGM Production Guidance
ProForm 6-KLGO · Form 6-K · 2026-08-14
FiEE Q2: Revenue Soars to $4.8M, But Going Concern Doubt and Material Weakness Loom
ProForm 10-QFIEE · Form 10-Q · 2026-08-14
Galaxy Digital's 13F Reveals $1.7B Portfolio: Heavy Bitcoin ETF Exposure and Massive Index Put Positions
Form 13F-HRGLXY · Form 13F-HR · 2026-08-14
Bally's Q2 10-Q Flags Going Concern Doubt and Material Weakness
ProForm 10-QBALY · Form 10-Q · 2026-08-14
Stemtech Q2 Revenue Falls 9.8%, Shares Outstanding Surge 543% as Convertible Debt Converts
ProForm 10-QSTEK · Form 10-Q · 2026-08-14
Western Uranium & Vanadium Posts Q2 Loss, Reiterates Going Concern Warning
ProForm 10-QWSTRF · Form 10-Q · 2026-08-14
Capricor Q2 Loss Widens to $40.7M; New HQ Lease and Insider Selling Plans Disclosed
ProForm 10-QCAPR · Form 10-Q · 2026-08-14
Sadot Group's Q2 Revenue Hits Zero, but TradeOS Platform Books First $1M in July
ProForm 8-KSDOT · Form 8-K · 2026-08-14
Innoviz Proxy Reveals Nasdaq Delisting Risk and Reverse Split Details
ProForm 6-KINVZ · Form 6-K · 2026-08-14
Elutia Faces Nasdaq Delisting, Secures $15M Loan, and Divests SimpliDerm
ProForm 10-QELUT · Form 10-Q · 2026-08-14
Interactive Strength Q2 Revenue Jumps 445% but Going Concern Doubts Persist
ProForm 10-QTRNR · Form 10-Q · 2026-08-14
Officer/Director Bradley Vizi Files to Sell 100,000 Shares Worth $3.5M
Form 144RCMT · Form 144 · 2026-08-14
PSB Financial Posts $1.4M Loss on Core Conversion Costs; Equity Surges After IPO
Form 10-QPNSB · Form 10-Q · 2026-08-14
Agassi Sports Registers 13.98M Shares for Resale at $6.40 Fixed Price
Form 424B3AASP · Form 424B3 · 2026-08-14
Foremost Clean Energy Reports Q1 Loss, Names Interim CEO, and Completes Denison Phase 2 Earn-In
Form 6-KFMST · Form 6-K · 2026-08-14
Nakamoto Q2: $133M Net Loss, $7.3M Adjusted Operating Income, $25M Buyback
Form 8-KNAKA · Form 8-K · 2026-08-14
Scilex Posts $115M Q2 Loss, Cash Dwindles to $0.6M, Going Concern Doubt Reiterated
ProForm 10-QSCLX · Form 10-Q · 2026-08-14
Nasdaq Delisting Notice Hits Teads as Stock Sinks Below $1
ProForm 8-KTEAD · Form 8-K · 2026-08-14
Fermi 10-Q: Going Concern Warning, Material Weakness, and $6.5B TensorWave Lease
ProForm 10-QFRMI · Form 10-Q · 2026-08-14
Jupiter Neurosciences 10-Q: Going Concern, Material Weakness, and PharmAla Deal Details
ProForm 10-QJUNS · Form 10-Q · 2026-08-14
CH4 Natural Solutions Flags Going Concern Doubt as Q2 Loss Hits $5.8M
ProForm 10-QMTNE · Form 10-Q · 2026-08-14
OneMedNet 10-Q Reveals New $25M Equity Line Terms and $1M Insider Purchase
ProForm 10-QONMD · Form 10-Q · 2026-08-14
AMD Discloses $1.3B Strategic Equity Portfolio, Including $565M SpaceX Stake
Form 13F-HRAMD · Form 13F-HR · 2026-08-14
BrainStorm 10-Q: Going Concern, Material Weakness, and New Litigation
ProForm 10-QBCLI · Form 10-Q · 2026-08-14
Anterix Officer's Sale Amended: $10M Disclosed, Up from $7.5M
Form 4/AATEX · Form 4/A · 2026-08-14
Laser Photonics Q2 2026: Losses Widen, New Material Weaknesses Disclosed
ProForm 10-QLASE · Form 10-Q · 2026-08-14